Regeneron Announces Presentation at Lehman Brothers Global Healthcare Conference

TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) will webcast its presentation at the Lehman Brothers Global Healthcare Conference on Thursday, March 20, 2008. The presentation will provide an overview of the Company and its clinical programs and is scheduled to be broadcast live on Thursday, March 20 at 11:15 a.m. Eastern Time. The session may be accessed through the Company’s web site (www.regeneron.com on the Investor Relations page, under the Presentations heading) at the time of the presentation. An archived version of the presentation will be available after the live webcast through April 19, 2008. Additional information about Regeneron and recent news releases are available on the Regeneron worldwide web site at www.regeneron.com

Regeneron is an integrated biopharmaceutical company that discovers, develops, and commercializes medicines for the treatment of serious medical conditions. In addition to ARCALYST™ (rilonacept) Injection for Subcutaneous Use, its first commercialized product, Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.